Axa’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-51,400
Closed -$4.01M 1086
2024
Q4
$4.01M Sell
51,400
-6,730
-12% -$525K 0.01% 596
2024
Q3
$4.67M Buy
58,130
+4,505
+8% +$362K 0.01% 568
2024
Q2
$4.44M Sell
53,625
-50
-0.1% -$4.14K 0.01% 558
2024
Q1
$4.58M Sell
53,675
-25
-0% -$2.13K 0.01% 573
2023
Q4
$4.59M Buy
53,700
+1,700
+3% +$145K 0.01% 569
2023
Q3
$4.66M Sell
52,000
-800
-2% -$71.7K 0.02% 545
2023
Q2
$4.5M Buy
52,800
+7,500
+17% +$639K 0.01% 577
2023
Q1
$3.75M Buy
+45,300
New +$3.75M 0.01% 635
2021
Q4
Sell
-4,500
Closed -$318K 1222
2021
Q3
$318K Buy
+4,500
New +$318K ﹤0.01% 1138
2021
Q2
Sell
-9,500
Closed -$1.06M 1268
2021
Q1
$1.06M Hold
9,500
﹤0.01% 970
2020
Q4
$1.13M Hold
9,500
﹤0.01% 954
2020
Q3
$829K Sell
9,500
-1,300
-12% -$113K ﹤0.01% 969
2020
Q2
$967K Hold
10,800
﹤0.01% 960
2020
Q1
$1.08M Buy
+10,800
New +$1.08M 0.01% 843
2017
Q4
Sell
-21,200
Closed -$951K 1367
2017
Q3
$951K Buy
+21,200
New +$951K ﹤0.01% 968
2017
Q2
Sell
-7,200
Closed -$292K 1263
2017
Q1
$292K Buy
+7,200
New +$292K ﹤0.01% 1165
2016
Q3
Sell
-21,800
Closed -$632K 1254
2016
Q2
$632K Buy
+21,800
New +$632K ﹤0.01% 959